Filing Details
- Accession Number:
- 0001140361-23-000876
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-06 21:30:20
- Reporting Period:
- 2023-01-05
- Accepted Time:
- 2023-01-06 21:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1635088 | Roivant Sciences Ltd. | ROIV | Pharmaceutical Preparations (2834) | 981173944 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801917 | Eric Venker | C/O Roivant Sciences Ltd. 7Th Floor, 50 Broadway London X0 SW1H 0DB | President & Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-01-05 | 24,037 | $8.02 | 729,429 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.
Billionaire Hedge Funds
